ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2019

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.

G V Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.